Hormone Receptor Positive Breast Carcinoma trials recruiting in Kansas

Fewer than 3 recruiting trials found.

All Hormone Receptor Positive Breast Carcinoma trials nationally

2

Recruiting in Kansas

9

Cities with sites

Cities in Kansas

Hays 1Kansas City 1Lawrence 1Olathe 1Overland Park 1Salina 1Topeka 1Westwood 1Wichita 1

Recruiting trials in Kansas

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Hays, Kansas City, Lawrence, Olathe
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
NCT04553770 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Kansas: Wichita

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.